In vitro mouse model in Duchenne muscular dystrophy diagnosis using 50-MHz ultrasound waves

被引:4
作者
Laux, D. [1 ]
Blasco, H. [1 ]
Ferrandis, J. Y. [1 ]
Hugon, G. [2 ]
Despaux, G. [1 ]
Leydier, A. [1 ]
Mornet, D. [2 ]
机构
[1] Univ Montpellier 2, Inst Elect Sud, IES, CNRS,UMR 5214, F-34095 Montpellier, France
[2] Univ Montpellier 1, INSERM, Unit Muscle & Pathol, ERI 25,EA 4202,CHU Arnaud Villeneuve, F-34295 Montpellier 5, France
关键词
Ultrasonic attenuation; DMD; Mdx and BL10 mice; MDX-MOUSE; DIAPHRAGM MUSCLE; MICE; ATTENUATION; EXPRESSION; VELOCITY; PROTEIN; LIVER; FAT;
D O I
10.1016/j.ultras.2010.04.003
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Duchenne muscular dystrophy (DMD) is caused by the absence of dystrophin, the protein that plays a key mechanical role in maintaining muscle membrane integrity. One of the major consequences of dystrophin deficiency is the degeneration of muscle fibres, with a progressive loss in muscle strength. The objective of this research was to find an ultrasonic parameter sensitive to DMD, which could give relevant information related to microstructure if compared to traditional investigations such as morphometrical analysis. This "in vitro" study focused on the Mdx mouse model and investigated the potential differences between wild-type and dystrophin-deficient mice diaphragms. Using a 50 MHz ultrasonic sensor built in our group, we recorded an increase in ultrasonic wave attenuation in the dystrophin-deficient samples in comparison with normal muscles. A correlation between attenuation, mouse age and the percentage of non-muscular proportion in muscle was observed. As Mdx mouse is the best animal model for DMD and reproduces the degenerative pattern observed in human DMD muscles, this approach could be a powerful tool for in vitro DMD investigation and, more generally, for the characterisation of muscle properties. (C) 2010 Elsevier B. V. All rights reserved.
引用
收藏
页码:741 / 743
页数:3
相关论文
共 15 条
[1]   Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse [J].
Briguet, A ;
Courdier-Fruh, I ;
Foster, M ;
Meier, T ;
Magyar, JP .
NEUROMUSCULAR DISORDERS, 2004, 14 (10) :675-682
[2]   Diaphragm muscle strip preparation for evaluation of gene therapies in mdx mice [J].
Faulkner, John A. ;
Ng, Rainer ;
Davis, Carol S. ;
Li, Sheng ;
Chamberlain, Jeffrey S. .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2008, 35 (07) :725-729
[3]   Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy [J].
Grounds, Miranda D. ;
Radley, Hannah G. ;
Lynch, Gordon S. ;
Nagaraju, Kanneboyina ;
De Luca, Annarnaria .
NEUROBIOLOGY OF DISEASE, 2008, 31 (01) :1-19
[4]   Pathological pattern of Mdx mice diaphragm correlates with gradual expression of the short utrophin isoform Up71 [J].
Hnia, K ;
Tuffery-Giraud, S ;
Vermaelen, M ;
Hugon, G ;
Chazalette, D ;
Masmoudi, A ;
Rivier, F ;
Mornet, D .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2006, 1762 (03) :362-372
[5]   Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice [J].
Hnia, Karim ;
Hugon, Gerald ;
Rivier, Francois ;
Masmoudi, Ahmed ;
Mercier, Jacques ;
Mornet, Dominique .
AMERICAN JOURNAL OF PATHOLOGY, 2007, 170 (02) :633-643
[6]   THE COMPLETE SEQUENCE OF DYSTROPHIN PREDICTS A ROD-SHAPED CYTOSKELETAL PROTEIN [J].
KOENIG, M ;
MONACO, AP ;
KUNKEL, LM .
CELL, 1988, 53 (02) :219-228
[7]   Ultrasonic properties of water/sorbitol solutions [J].
Laux, D. ;
Leveque, G. ;
Camara, V. Cereser .
ULTRASONICS, 2009, 49 (02) :159-161
[8]   Correction of diffraction effects in sound velocity and absorption measurements [J].
Leveque, G. ;
Rosenkrantz, E. ;
Laux, D. .
MEASUREMENT SCIENCE AND TECHNOLOGY, 2007, 18 (11) :3458-3462
[9]   CORRELATION OF ULTRASONIC-ATTENUATION WITH PATHOLOGIC FAT AND FIBROSIS IN LIVER-DISEASE [J].
LIN, T ;
OPHIR, J ;
POTTER, G .
ULTRASOUND IN MEDICINE AND BIOLOGY, 1988, 14 (08) :729-734
[10]   Therapeutic approaches for muscle wasting disorders [J].
Lynch, Gordon S. ;
Schertzer, Jonathan D. ;
Ryall, James G. .
PHARMACOLOGY & THERAPEUTICS, 2007, 113 (03) :461-487